NCT03586635已完成不适用
Automated EDSS Score Calculation Using a Smartphone Application in Multiple Sclerosis Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 105
- 试验地点
- 1
- 主要终点
- EDSS score apllication VS paper version
研究概览
简要总结
The EDSS score is the reference tool for rating disability in patients with multiple sclerosis. It is used in both daily monitoring and clinical research studies.
Its main shortcoming lies in its imprecise and variable nature, with significant inter-examiner variability. This variability is the consequence of the complexity of the score rating and also of its subjective nature.
The application developed aims to reduce the risk of rating error, and to homogenize the results obtained regardless of the examiner and his experience in using the score.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with multiple sclerosis seen at the Central Nervous System Day Hospital as part of their follow-up and requiring neurological examination.
- •Age ≥ 18 years
- •No opposition to the use of their data
排除标准
- •Neurological or general pathology, other than multiple sclerosis, that may interfere with EDSS score scoring
结局指标
主要结局
EDSS score apllication VS paper version
时间窗: 6 months
comparison of the overall EDSS score obtained with the application and its paper version at the end of the neurological examination
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.Multiple SclerosisNCT04595799Centre Hospitalier Universitaire de Nice240
已完成
不适用
Neurostatus-SMARTCARE in Comparison to Standard Neurostatus-EDSS®Multiple Sclerosis (MS)NCT05575843University Hospital, Basel, Switzerland101
Enrolling By Invitation
不适用
Vision-based Assessment of Joint Extensibility in Ehlers Danlos SyndromeEhlers-Danlos SyndromeNCT05366114University Health Network, Toronto225
已完成
不适用
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy ResponseMultiple SclerosisMSNCT03316404DxTerity Diagnostics1,168
进行中（未招募）
不适用
DreaMS - Validation Study 1Multiple SclerosisNCT05009160Research Center for Clinical Neuroimmunology and Neuroscience Basel300